Axoft, a neurotechnology company, has secured an oversubscribed $55 million Series A funding round, bringing its total raised to over $60 million. This significant capital infusion, led by C.P. Group Innovation with participation from Alumni Ventures, Stanford President’s Venture Fund, Hillhouse Investment, and Gaorong Ventures, will fuel the expansion of its global clinical trials and advance U.S. regulatory approval for its implantable Brain-Computer Interface.
